Revolution Medicines, Inc. (RVMD) stock
RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
$159.82−2.87 (-1.76%)
Close on Nov 18, 2026Market cap $34.26BP/E –Yield –
Revolution Medicines price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Revolution Medicines's price to book ratio was 14.9× on Nov 11, 2026, against 9.2× a year earlier. Over the last 5 years it ranged from 2.3× to 25.0×, with a median of 3.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 14.9× | +5.4 |
| 2025 | Dec 31, 2025 | 9.5× | +4.8 |
| 2024 | Dec 31, 2024 | 4.7× | +0.9 |
| 2023 | Dec 29, 2023 | 3.7× | +0.7 |
| 2022 | Dec 30, 2022 | 3.1× | +0.2 |
| 2021 | Dec 31, 2021 | 2.9× | −2.3 |
| 2020 | Dec 31, 2020 | 5.2× | – |
See a number that looks wrong?